169 related articles for article (PubMed ID: 32690632)
21. Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis challenge in mice.
Jain-Gupta N; Contreras-Rodriguez A; Vemulapalli R; Witonsky SG; Boyle SM; Sriranganathan N
FEMS Immunol Med Microbiol; 2012 Dec; 66(3):436-44. PubMed ID: 23163875
[TBL] [Abstract][Full Text] [Related]
22. Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.
Clapp B; Skyberg JA; Yang X; Thornburg T; Walters N; Pascual DW
Infect Immun; 2011 Oct; 79(10):4165-74. PubMed ID: 21768283
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a Brucella melitensis mutant deficient in O-polysaccharide export system ATP-binding protein as a rough vaccine candidate.
Wang Z; Niu JR; Wang XL; Wu TL; Cheng J; Lu L; Wu QM
Microbes Infect; 2014 Aug; 16(8):633-9. PubMed ID: 25043564
[TBL] [Abstract][Full Text] [Related]
24. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
[TBL] [Abstract][Full Text] [Related]
25. Brucella melitensis M5-90Δbp26 as a potential live vaccine that allows for the distinction between natural infection and immunization.
Li T; Tong Z; Huang M; Tang L; Zhang H; Chen C
Can J Microbiol; 2017 Aug; 63(8):719-729. PubMed ID: 28482164
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis.
Kahl-McDonagh MM; Elzer PH; Hagius SD; Walker JV; Perry QL; Seabury CM; den Hartigh AB; Tsolis RM; Adams LG; Davis DS; Ficht TA
Vaccine; 2006 Jun; 24(24):5169-77. PubMed ID: 16697090
[TBL] [Abstract][Full Text] [Related]
27. Brucella abortus in Bison. II. Evaluation of strain 19 vaccination of pregnant cows.
Davis DS; Templeton JW; Ficht TA; Huber JD; Angus RD; Adams LG
J Wildl Dis; 1991 Apr; 27(2):258-64. PubMed ID: 1906114
[TBL] [Abstract][Full Text] [Related]
28. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
[TBL] [Abstract][Full Text] [Related]
29. An influenza viral vector Brucella abortus vaccine induces good cross-protection against Brucella melitensis infection in pregnant heifers.
Tabynov K; Ryskeldinova S; Sansyzbay A
Vaccine; 2015 Jul; 33(31):3619-23. PubMed ID: 26093199
[TBL] [Abstract][Full Text] [Related]
30. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats.
Blasco JM
Prev Vet Med; 1997 Aug; 31(3-4):275-83. PubMed ID: 9234451
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the immunogenicity and safety of Brucella melitensis B115 vaccination in pregnant sheep.
Pérez-Sancho M; Adone R; García-Seco T; Tarantino M; Diez-Guerrier A; Drumo R; Francia M; Domínguez L; Pasquali P; Álvarez J
Vaccine; 2014 Apr; 32(16):1877-81. PubMed ID: 24508034
[TBL] [Abstract][Full Text] [Related]
32. Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model.
Uslu A; Erganis O
Mol Immunol; 2021 May; 133():44-52. PubMed ID: 33631554
[TBL] [Abstract][Full Text] [Related]
33. Pathological changes, distribution and detection of
Mazlan M; Khairani-Bejo S; Hamzah H; Nasruddin NS; Salleh A; Zamri-Saad M
Vet Q; 2021 Dec; 41(1):36-49. PubMed ID: 33349157
[TBL] [Abstract][Full Text] [Related]
34. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA
Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263
[TBL] [Abstract][Full Text] [Related]
35. Development and characterization of mouse models of infection with aerosolized Brucella melitensis and Brucella suis.
Smither SJ; Perkins SD; Davies C; Stagg AJ; Nelson M; Atkins HS
Clin Vaccine Immunol; 2009 May; 16(5):779-83. PubMed ID: 19321692
[TBL] [Abstract][Full Text] [Related]
36. Control of Brucella melitensis infection in a large camel herd in Saudi Arabia using antibiotherapy and vaccination with Rev. 1 vaccine.
Radwan AI; Bekairi SI; Mukayel AA; al-Bokmy AM; Prasad PV; Azar FN; Coloyan ER
Rev Sci Tech; 1995 Sep; 14(3):719-32. PubMed ID: 8593404
[TBL] [Abstract][Full Text] [Related]
37. Immunotherapeutics to prevent the replication of Brucella in a treatment failure mouse model.
Jain-Gupta N; Contreras-Rodriguez A; Smith GP; Garg VK; Witonsky SG; Isloor S; Vemulapalli R; Boyle SM; Sriranganathan N
Vaccine; 2014 Feb; 32(8):918-23. PubMed ID: 24397905
[TBL] [Abstract][Full Text] [Related]
38. Induction of protective immunity against brucellosis in mice by vaccination with a combination of naloxone, alum, and heat-killed Brucella melitensis 16 M.
Motaharinia Y; Rezaee MA; Rashidi A; Jalili A; Rezaie MJ; Shapouri R; Hossieni W; Rahmani MR
J Microbiol Immunol Infect; 2013 Aug; 46(4):253-8. PubMed ID: 22727892
[TBL] [Abstract][Full Text] [Related]
39. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
Wang Y; Bai Y; Qu Q; Xu J; Chen Y; Zhong Z; Qiu Y; Wang T; Du X; Wang Z; Yu S; Fu S; Yuan J; Zhen Q; Yu Y; Chen Z; Huang L
Vet Microbiol; 2011 Aug; 151(3-4):354-62. PubMed ID: 21530111
[TBL] [Abstract][Full Text] [Related]
40. Vaccination control programs for multiple livestock host species: an age-stratified, seasonal transmission model for brucellosis control in endemic settings.
Beauvais W; Musallam I; Guitian J
Parasit Vectors; 2016 Jan; 9():55. PubMed ID: 26825313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
